Latest News & Features
Americas
Indian drug maker Ranbaxy Laboratories has sued the US Food and Drug Administration and claimed it wrongfully revoked a previous approval for two new drugs. 19 November 2014
Biotechnology
The US Court of Appeals for the Federal Circuit has denied pharmaceutical company Antares Pharma an injunction that aimed to block a rival from allegedly infringing a patent covering injection devices. 18 November 2014
Americas
US-based law firm Quarles & Brady has expanded its life sciences team with the addition of a new partner. 18 November 2014
Asia
The heads of the European Patent Office and China’s IP office have pledged to work together to improve innovation and future partnerships. 17 November 2014
Americas
US pharmaceutical company Sucampo Pharmaceuticals has sued India-based Dr. Reddy’s Laboratories, asserting patents covering its constipation treatment Amitiza (lubiprostone). 13 November 2014
Big Pharma
The sale of counterfeit drugs is the target of new legislation proposed by the Russian government, according to news agency Tass. 12 November 2014
Americas
Healthcare company PDL BioPharma has announced that it will soon gain royalties from sales of Sanofi’s Cerdelga (eliglustat) drug, used to treat Gaucher disease. 11 November 2014
Asia
The European Patent Office has agreed a new deal with the Intellectual Property Office of India designed to support innovation in both regions. 10 November 2014
Americas
Glenmark Generics has been granted approval to market a generic version of AstraZeneca’s ulcer treatment drug Prilosec (omeprazole delayed release capsules). 7 November 2014
Biotechnology
Law firm Eversheds has expanded its IP practice in Belgium with the addition of a new life sciences partner. 6 November 2014